[{"Assets_0_Q2_USD":345783000.0,"CommonStockSharesOutstanding_0_Q2_shares":81632045.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":20952000.0,"NetIncomeLoss_1_Q2_USD":-380000.0,"NetIncomeLoss_2_Q2_USD":264000.0,"StockholdersEquity_0_Q2_USD":164209000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":90168000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":89305000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":81017000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":80789000.0,"Ticker":"NEO","CIK":"1077183","name":"NEOGENOMICS INC","OfficialName":"NeoGenomics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1483151019.0","Country":"United States","Sector":"Health Care","Industry":"Precision Instruments","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]